Links 🖇️

Pitch Deck / Website

Journey ⛰️

SANNT began as a consulting firm helping universities commercialize innovative technologies. The team quickly pivoted to independently accelerate the development of eye care technologies, creating a focused company that harvests promising eye care innovations stalled within institutions. SANNT licenses these technologies, forms new companies around these assets, drives development toward commercialization, and positions these ventures for acquisition by multinational eye care companies.

Location 🗺️

HQ: 7720 Rivers Edge Drive, Suite 101, Columbus, OH 43235
Market Presence: Working with top-tier ophthalmic institutions across the country

Meet the Leadership 🤼

Contact email: mpuwal@sannt.us

• Mark Puwal (Chief Operating Officer)
• Robin Sears (Executive Chairman)
• Brad Beasecker (Chief Financial Officer)
• TJ Bowen (Chief Technology/Scientific Officer)
• Paul Grimm (Operating Executive)
• Gordon Bethwaite (Operating Executive)
• Jayne Frilling (Project Coordinator)

Alignment 💫

• Key Achievements:
  • Developed proprietary “SANNT Engine” for technology commercialization
  • Formed two new companies with innovative eye care assets positioned for acquisition
  • Established relationships with leading eye care professionals, investment bankers, IP experts, and senior executives at major eye care companies
• Strategic Partners:
  • Life Science Manufacturing Organizations
  • Top-tier ophthalmic institutions
  • World-leading eye care professionals
  • Investment bankers
  • IP legal experts
  • Senior executives at major eye care companies
• Upcoming Milestones:
  • Scale and strengthen SANNT through capital raise
  • Form a new portfolio company every 12-18 months
  • Establish consistent cadence of liquidity events

Round Details 💰

Contact Pauly or the leadership team above.

Exit Strategy 🚪

SANNT’s business model focuses on creating portfolio companies around eye care technologies and selling these companies to strategic multinational global eye care companies, creating a consistent cadence of liquidity events over time.

Asks 🙋

• Strategic partnerships with eye care and life science institutions
• Support in accelerating technology development and commercialization
• Assistance in building and identifying eye care technology to license and patent